Key Facts

  • Lilly at a Glance

    • A heritage more than 140 years strong: company founded on May 10, 1876
    • Headquarters located in Indianapolis, Indiana, U.S.A.
    • Approximately 33,000 employees worldwide
    • More than 7,800 employees engaged in research and development
    • Clinical research conducted in more than 55 countries
    • Research and development facilities located in 8 countries
    • Manufacturing plants located in 8 countries
    • Products marketed in 120 countries
  • Employees

    (as of December 31, 2019)

    • Indianapolis: 10,737
    • Indiana (excluding Indianapolis): 82
    • U.S. (excluding Indiana): 3,888
    • Outside U.S.: 18,917
    • Worldwide total: 33,624
  • 2019 Financials

    (dollars in millions, except per-share data)

    • Net sales: $22,319.5
    • Net income as reported: $8,318.4
    • Net income non-GAAP: $5,568.2
    • Earnings per share as reported: $8.89
    • Earnings per share non-GAAP: $6.04
    • Dividends paid per share: $2.58
  • Research & Development

    2019 Expenditures

    • $5,595 million/year
    • $21.5 million/workday
    • R&D as a percentage of sales: 25.1%
    • Employees engaged in R&D activities: 7,811
    • Percentage of total workforce: 23%
  • Cost of Pharmaceuticals

    • Average cost to discover and develop a new drug: $2.6 billion
    • Average length of time from discovery to patient: 10 years